Active substanceDextroseDextrose
Similar drugsTo uncover
  • Glucose
    solution d / infusion 
  • Glucose
    solution in / in 
    GROTEKS, LLC     Russia
  • Glucose
    solution d / infusion 
  • Glucose
    solution in / in 
  • Glucose
    solution d / infusion 
    GROTEKS, LLC     Russia
  • Glucose
    solution d / infusion 
    PIELDZHI, LLC     Russia
  • Glucose
    solution d / infusion 
    ATOLL, LLC     Russia
  • Glucose
    solution in / in 
  • Glucose
    solution in / in 
    ALVILS, LTD.     Russia
  • Glucose
    solution d / infusion 
    ATOLL, LLC     Russia
  • Glucose
    solution in / in 
    ATOLL, LLC     Russia
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
    POLISAN NTPF, LLC     Russia
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
  • Glucose
    solution in / in 
  • Glucose
    solution d / infusion 
    Baxter S.L.     Spain
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
    SAMSON-MED, LLC     Russia
  • Glucose
    solution in / in 
  • Glucose
    pills inwards 
  • Glucose
    solution d / infusion 
    ALIUM PFK, LLC     Russia
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
    GEMATEK, LLC     Russia
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
  • Glucose
    solution in / in 
    BINNOFARM, CJSC     Russia
  • Glucose
    solution d / infusion 
  • Glucose
    solution in / in 
  • Glucose
    solution d / infusion 
    BIOSINTEZ, PAO     Russia
  • Glucose
    solution in / in 
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
    DALHIMFARM, OJSC     Russia
  • Glucose
    solution in / in 
  • Glucose
    solution in / in 
    BIOSINTEZ, PAO     Russia
  • Glucose
    solution d / infusion 
  • Glucose
    solution in / in 
    DALHIMFARM, OJSC     Russia
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
    SAKHAMEDPROM, SUE     Russia
  • Glucose
    solution d / infusion 
    RESTER, CJSC     Russia
  • Glucose
    solution d / infusion 
  • Glucose
    solution d / infusion 
    KRASFARMA, JSC     Russia
  • Glucose
    solution d / infusion 
    Kelun-Kazfarm, TOO     The Republic of Kazakhstan
  • Glucose Brown
    solution d / infusion 
  • Glucose bufus
    solution in / in 
    UPDATE OF PFC, CJSC     Russia
  • Glucose-Vial
    solution d / infusion 
    VIAL, LLC     Russia
  • Glucose-E
    solution d / infusion 
    ESKOM NPK, OAO     Russia
  • Glucose-Eskom
    solution in / in 
    ESKOM NPK, OAO     Russia
  • Glucose solution for infusions
    solution d / infusion 
    ALTAYVITAMINS, CJSC     Russia
  • Glucosterol
    solution d / infusion 
  • Dosage form: & nbspsolution for intravenous administration
    Composition:

    Per 1 ml:

    active substances: dextrose monohydrate (glucose) (in terms of anhydrous) 400 mg;

    Excipients: sodium chloride, hydrochloric acid solution 0.1 M, water for injection.

    Description:Transparent, colorless or light yellow liquid.
    Pharmacotherapeutic group:Nutrition carbohydrate remedy
    ATX: & nbsp

    B.05.C   Irrigation solutions

    V.06.D   Other medications for nutrition

    V.04.C   Other diagnostic preparations

    Pharmacodynamics:

    Participates in various metabolic processes in the body. The infusion of glucose solutions partially replenishes the water deficiency. Dextrose, entering the tissue, phosphorylated, turning into glucose-6-phosphate, which is actively included in many parts of the body's metabolism.

    Hypertonic solution of dextrose increases osmotic blood pressure, increases diuresis.

    Pharmacokinetics:

    It is absorbed completely by the body, the kidneys are not excreted (the appearance in the urine is a pathological sign).

    Indications:

    Hypoglycemia.

    When diluted to 5-10% solution: insufficiency of carbohydrate nutrition, toxicinfection, intoxication in liver diseases (hepatitis, dystrophy and atrophy of the liver, including liver failure), hemorrhagic diathesis; dehydration (vomiting, diarrhea, postoperative period); intoxication; collapse, shock; in the complete parenteral nutrition.

    Contraindications:

    Hyperglycemia, hypersensitivity to drug components, hyperlactatemia, hyperhydration, postoperative glucose utilization disorders; circulatory disorders that threaten edema of the brain and lungs; cerebral edema, pulmonary edema, acute left ventricular failure, hyperosmolar coma, children's age (for solutions over 20-25%), pregnancy, lactation.

    Carefully:

    Decompensated chronic heart failure, chronic renal failure (oligo, anuria), hyponatremia, diabetes mellitus.

    Pregnancy and lactation:

    The purpose of the drug during pregnancy and lactation is possible only according to the doctor's prescription, if the intended benefit for the mother exceeds the potential risk to the fetus or baby.

    Dosing and Administration:
    Method of dilution of 40% glucose solution to obtain a solution of the required concentration:

    To prepare a 5% solution of glucose it is necessary to take 1 part of 40% glucose solution and 7 parts water, i.e. Displace 5 ml of 40% glucose solution with 35 ml of water for injection (for an ampoule of 5 ml), or mix 10 ml of a 40% glucose solution with 70 ml of water for injection (for a 10 ml ampoule).

    To prepare 10% glucose solution it is necessary to take 1 part 40% solution of glucose and 3 parts of water, ie: mix 5 ml of 40% glucose solution with 15 ml of water for injection (for a 5 ml ampoule), or mix 10 ml of 40% glucose solution with 30 ml of water for injection (for a 10 ml ampoule).

    To prepare 20% glucose solution it is necessary to take 1 part 40% glucose solution and 1 part of water, ie: mix 5 ml of 40% glucose solution with 5 ml of water for injection (for an ampoule of 5 ml), or mix 10 ml of 40% glucose solution with 10 ml of water for injection (for ampoules volume of 10 ml).

    To prepare 25% glucose solution it is necessary to take 1 part of a 40% solution of glucose and 0.6 parts of water, ie: mix 5 ml of 40% glucose solution with 3 ml of water for injection (for a 5 ml ampoule), or mix 10 ml of 40% glucose solution with 6 ml of water for injection (for a 10 ml ampoule).

    Intravenously, drip.

    5% solution injected at a maximum rate of up to 7 ml (150 cap / min) (400 ml / h); the maximum daily intake for adults is 2 liters.

    10% solution - up to 60 cap / min (3 ml / min); the maximum daily intake for adults is 1L.

    20% solution - up to 30-40 cap / min 1,5-2 ml / min; the maximum daily intake for adults is 500 ml.

    40% solution - up to 30 cap / min (1.5 ml / min); the maximum daily intake for adults is 250 ml.

    Intravenously, intravenously - 10-50 ml of 5 and 10% solutions.

    In adults with a normal metabolism, the daily dose of dextrose administered should not exceed 4-6 g / kg, i.e. about 250-450 g (with a decrease in the metabolic rate, the daily dose is reduced to 200-300 g), while the daily volume of the injected liquid is 30-40 ml / kg.

    Children for parenteral nutrition, along with fats and amino acids, 6 g of dextrose / kg / day are administered on the first day, followed by up to 15 g / kg / day.

    Rate of administration: at a normal state of metabolism, the maximum rate of glucose administration to adults is 0.25-0.5 g / kg / h (with a decrease in metabolic rate, the rate of administration is reduced to 0.125-0.25 g / kg / h). Children use solutions with a concentration of not more than 20-25%; the rate of dextrose administration should not exceed 0.75 g / kg / h.

    When calculating the dose of dextrose with the administration of 5 and 10% solutions, one must take into account allowable volume of injected liquid: for children with a body weight of 2-10 kg - 100-165 ml / kg / day, children with a body weight of 10-40 kg - 45-100 ml / kg / day.

    For a more complete assimilation of glucose, administered in large doses, concomitantly with it prescribe insulin of short action, from the calculation of 1 unit of short-acting insulin for 4-5 g of glucose.

    Patients with diabetes mellitus are administered glucose under the control of its content in the blood and urine.

    Side effects:

    Hyperglycemia, fever, hypervolemia, acute left ventricular failure.

    At the injection site - the development of infection, thrombophlebitis.

    Overdose:

    Symptoms: hyperglycemia, glucosuria, hyperglycemic hyperosmolar coma, hyperhydration, disturbance of water-electrolyte balance, enhancement of liponeogenesis with increased production of CO2, which leads to a sharp increase in the minute respiratory volume, and, as a consequence, the respiratory rate; fatty liver infiltration.

    Treatment: stop the introduction of glucose, introduce short-acting insulin, symptomatic therapy.

    Interaction:

    When combined with other drugs, it is necessary to visually control the pharmaceutical compatibility.

    Special instructions:

    For a more complete and rapid assimilation of dextrose, it is possible to inject 4-5 units of insulin of short action subcutaneously, at the rate of 1 unit of short-acting insulin for 4-5 g of dextrose.

    When introducing dextrose solutions, control of electrolyte balance, dextrose content in blood and urine is necessary.

    Form release / dosage:

    Solution for intravenous administration, 40%.

    Packaging:
    By 5 ml or 10 ml into ampoules of neutral glass HC-3.

    10 ampoules together with the instruction for use are placed in a pack of cardboard. Packs are pasted with a label-parcel. It is allowed to put the text of the label-parcel directly on the packet.

    Five ampoules are placed in a contour mesh box made of a polyvinylchloride film and aluminum foil, or paper wrapped with a polymer coating, or without paper and foil.

    2 contour squares, together with instructions for use, are placed in a pack of cardboard and a sticker is applied. It is allowed to put the text of the label-parcel directly on the packet.

    In each pack insert knife ampoule or scarifier. When packaging ampoules with a dot or ring fracture, the ampoule opener or scarifier is not inserted.

    Storage conditions:

    In the dark place at a temperature of 0 to 30 ° C.

    Freezing is allowed.

    Keep out of the reach of children.

    Shelf life:

    5 years.

    He use at expiration date.

    Terms of leave from pharmacies:On prescription
    Registration number:LSR-008846/10
    Date of registration:30.08.2010 / 03.02.2015
    Expiration Date:Unlimited
    The owner of the registration certificate:Armavir Biofactory, FKPArmavir Biofactory, FKP Russia
    Manufacturer: & nbsp
    Information update date: & nbsp21.04.2017
    Illustrated instructions
      Instructions
      Up